Christos E Kyriakopoulos (Christos Kyriakopoulos)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Circulating Tumor

Renal Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yohann Loriot, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Petros D Grivas, Aude Flechon, Rohit K Jain, Umang Swami, Manojkumar Bupathi, Philippe Barthélémy, Philippe Beuzeboc, Phillip L Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Julia Tonelli, Mitch Sierecki, Marianna Zavodovskaya, Emon Elboudwarej, Lauri Diehl, Juliane M Jürgensmeier, Scott T Tagawa
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar G Kozlova, Kevin G Chan, Sara Lewis, Bassam El Achkar, Tanya B Dorff, Jeremy Paul Cetnar, Brock O Neil, Anishka D'Souza, Ronac Mamtani, Christos E Kyriakopoulos, Tomi Jun, Anisha Mahalya Gogerly-Moragoda, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Amir Horowitz, Yayoi Kinoshita, Ethan Ellis, Yohei Nose, Giorgio Ioannou, Rafael Cabal, Diane M Del Valle, G Kenneth Haines, Li Wang, Kent W Mouw, Robert M Samstein, Reza Mehrazin, Nina Bhardwaj, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, Robert P Sebra, Jun Zhu, Sacha Gnjatic, John Sfakianos, Sumanta Kumar Pal
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine (2024)
Douglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, Christos E Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli, Laura E Johnson, Glenn Liu
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. Journal for immunotherapy of cancer 11 (12) (2023)
Douglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, Christos E Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli, Laura E Johnson, Glenn Liu
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. Journal for immunotherapy of cancer 11 (12) (2023)
Douglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, Christos E Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli, Laura E Johnson, Glenn Liu
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. Journal for immunotherapy of cancer 11 (12) (2023)
Douglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, Christos E Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli, Laura E Johnson, Glenn Liu
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. Journal for immunotherapy of cancer 11 (12) (2023)
Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R Kaufmann, David J Niles, Erika Heninger, Nicholas R Rydzewski, Liguo Wang, Liewei Wang, Rendong Yang, Yanan Ren, Johnathan W Engle, Peng Huang, Christos E Kyriakopoulos, Susan F Slovin, Howard R Soule, Shuang G Zhao, Manish Kohli, Scott T Tagawa, Weibo Cai, Scott M Dehm, Joshua M Lang
Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth Pan, Wanling Xie, Archana Ajmera, Arlene Araneta, Christina A M Jamieson, Edmund Folefac, Arif Hussain, Christos E Kyriakopoulos, Adam C Olson, Mamta Parikh, Rahul A Parikh, Biren Saraiya, Susan Percy Ivy, Eliezer Van Allen, Neal I Lindeman, Bose S Kochupurakkal, Geoffrey I Shapiro, Rana R McKay
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Molecular cancer therapeutics (2023)
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar G Kozlova, Kevin G Chan, Sara Lewis, Bassam El Achkar, Tanya B Dorff, Jeremy Paul Cetnar, Brock O Neil, Anishka D'Souza, Ronac Mamtani, Christos E Kyriakopoulos, Tomi Jun, Anisha Mahalya Gogerly-Moragoda, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Amir Horwitz, Yayoi Kinoshita, Ethan Ellis, Yohei Nose, Giorgio Ioannou, Rafael Cabal, G Kenneth Haines, Li Wang, Kent W Mouw, Robert M Samstein, Reza Mehrazin, Nina Bhardwaj, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, Robert P Sebra, Jun Zhu, Sacha Gnjatic, John Sfakianos, Sumanta Kumar Pal
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine (2023)
Joanna M Streck, Ju-Whei Lee, Angela Wangari Walter, Rachel L Rosen, Ilana F Gareen, Sheetal Mehta Kircher, Benjamin A Herman, Ruth C Carlos, Shaji K Kumar, Ingrid A Mayer, Nabil F Saba, Timothy S Fenske, Joel W Neal, Michael B Atkins, Frank Stephen Hodi, Christos E Kyriakopoulos, Clare M C Tempany-Afdhal, Tait D Shanafelt, Lynne I Wagner, Stephanie R Land, Elyse R Park, Jamie S Ostroff
Cigarette and alternative tobacco product use among adult cancer survivors enrolled in 9 ECOG-ACRIN clinical trials. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Douglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, Christos E Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli, Laura E Johnson, Glenn Liu
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. Journal for immunotherapy of cancer 11 (12) (2023)
Douglas G McNeel, Jens C Eickhoff, Ellen Wargowski, Laura E Johnson, Christos E Kyriakopoulos, Hamid Emamekhoo, Joshua M Lang, Mary Jane Brennan, Glenn Liu
Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer 10 (3) (2022)
Matthew L Bootsma, Rana R McKay, Hamid Emamekhoo, Rory M Bade, Jennifer L Schehr, Matthew C Mannino, Anupama Singh, Serena K Wolfe, Zachery D Schultz, Jamie M Sperger, Wanling Xie, Sabina Signoretti, Christos E Kyriakopoulos, David Kosoff, Edwin J Abel, Kyle T Helzer, Nicholas Rydzewski, Hamza Bakhtiar, Yue Shi, Grace Blitzer, Michael Bassetti, John M Floberg, Menggang Yu, Nan Sethakorn, Marina N Sharifi, Paul M Harari, Toni K Choueiri, Joshua M Lang, Shuang G Zhao
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Scott T Tagawa, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot, Aude Fléchon, Rohit K Jain, Archana M Agarwal, Manojkumar Bupathi, Philippe Barthelemy, Philippe Beuzeboc, Phillip Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Quan Hong, Trishna Goswami, Loretta M Itri, Petros D Grivas
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Christos E Kyriakopoulos, Jens C Eickhoff, Anna C Ferrari, Michael T Schweizer, Ellen Wargowski, Brian M Olson, Douglas G McNeel
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Rana R McKay, Bradley Alexander McGregor, Wanling Xie, David A Braun, Xiao Wei, Christos E Kyriakopoulos, Yousef Zakharia, Benjamin L Maughan, Tracy L Rose, Walter M Stadler, David F McDermott, Lauren C Harshman, Toni K Choueiri
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)